Claims
- 1. A compound selected from those of formula (I), ##STR33## in which: the dotted line indicates the optional presence of a double bond,
- R represents the following group: ##STR34## in which: R.sub.5 represents hydrogen or linear or branched (C.sub.1 -C.sub.6)alkyl
- 2. A compound of claim 1, selected from those wherein R represents (1, 2-dihydro-2,2-dimethylquinol-4-yl)methyl, optionally substituted as in Formula H in claim 1, its enantiomers, and its addition salts with a pharmaceutically acceptable acid.
- 3. A compound of formula (I) as claimed in claim 1, which is 5-[4-[(6-ethoxy-1,2-dihydro -2,2-dimethylquinol-4-yl)methoxy]Benzyl]-2,4-thiazolidinedione and its addition salts with a pharmaceutically-acceptable acid.
- 4. A method for treating an animal or human living body afflicted with diabetes or obesity, comprising the step of administering to the living body an amount of a compound of claim 1 which is effective for alleviation of said conditions.
- 5. A pharmaceutical composition, useful for treating diabetes, or obesity, comprising as active principle an effective amount of a compound as claimed in claim 1, together with one or more pharmaceutically-acceptable excipients or vehicles.
Priority Claims (1)
Number |
Date |
Country |
Kind |
91 10430 |
Aug 1991 |
FRX |
|
Parent Case Info
The present application is a division of our prior-filed copending application Ser. No. 07/930,001, filed Aug. 14, 1992, now U.S. Pat. No. 5,266,582.
Foreign Referenced Citations (2)
Number |
Date |
Country |
8203 |
Feb 1980 |
EPX |
207581 |
Jan 1987 |
EPX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
930001 |
Aug 1992 |
|